The first and only feline broad-spectrum parasite protection that kills tapeworms.
One-And-Done Monthly Parasite Protection
One-And-Done Monthly Parasite Protection
New NexGard® COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) is the first and only broad-spectrum parasiticide for felines that protects against fleas and ticks, prevents heartworm disease, and treats and controls roundworms, hookworms, and tapeworms. It is a first-of-its-kind formulation that includes esafoxolaner—specifically developed for use in cats.
Uncover the Innovation
NexGard COMBO topical solution is the innovative feline parasite protection from a company with a history of efficacy and safety in parasiticides. Click each card below to discover what makes
NexGard COMBO topical solution unique.
NexGard COMBO topical solution offers one broad-spectrum solution for treating and controlling tapeworms, preventing heartworm disease, treating and controlling hookworms and roundworms, and killing fleas and ticks.
With an easy-to-use plunger applicator, NexGard COMBO topical solution provides one-and-done monthly protection against fleas and ticks, prevents heartworm disease, and treats and controls hookworms, roundworms, and tapeworms.
The Science Behind the Solution
NexGard COMBO topical solution combines the power of 3 active ingredients: esafoxolaner (designed specifically for felines), eprinomectin, and praziquantel. NexGard COMBO topical solution is the first-ever broad-spectrum, isoxazoline-based parasiticide for cats that is indicated to treat tapeworms.
2 Presentations for Convenient Storage
Specifically formulated for your feline patients, NexGard COMBO topical solution is available in 2 weight range sizes to cover the majority of cats and kittens. NexGard COMBO topical solution is safe for kittens at 8 weeks of age or older, weighing as little as 1.8 pounds.
Arm Your Clients With Tapeworm Education
NexGard COMBO topical solution is the only broad-spectrum parasite protection for felines that features tapeworm coverage, setting it apart from all other treatments of its class. Now, it’s easier than ever to make tapeworm coverage a part of your feline patients’ monthly parasite protection. Click the button to access a tapeworm education page to share with clients.
(esafoxolaner, eprinomectin, and
praziquantel topical solution)
NexGard® COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) provides powerful protection for your feline patients. It is the first and only topical broad-spectrum parasite treatment that protects against fleas and ticks, prevents heartworm disease, and treats and controls roundworms, hookworms, and tapeworms, in a single monthly topical application.
NexGard COMBO topical solution is safe for felines 8 weeks of age and older, weighing 1.8 lbs or more.
NexGard® COMBO topical solution is indicated for the prevention of heartworm disease caused by Dirofilaria immitis. NexGard® COMBO kills adult Ctenocephalides felis fleas and is indicated for the treatment and prevention of flea infestations, the treatment and control of black-legged tick (Ixodes scapularis) and lone star tick (Amblyomma americanum) infestations, and the treatment and control of roundworms (fourth-stage larval and adult Toxocara cati), hookworms (fourth-stage larval and adult Ancylostoma tubaeforme; adult Ancylostoma braziliense), and tapeworms (Dipylidium caninum).
NexGard® COMBO topical solution is dosed at a minimum of 0.055 mL/lb (0.12 mL/kg), which delivers a minimum dose of 0.65 mg/lb (1.44 mg/kg) esafoxolaner, 0.22 mg/lb (0.48 mg/kg) eprinomectin, and 4.53 mg/lb (9.98 mg/kg) praziquantel.
For heartworm disease prevention, apply once monthly for at least 3 months after last exposure to mosquitoes. Administer the entire contents of a NexGard® COMBO unit applicator topically once a month as specified in the following table:
To apply NexGard® COMBO topical solution, use scissors to cut the blister along the dotted line, then pull the lid away. Remove the applicator from the package and hold it upright. Pull back the plunger slightly, then twist and pull off the cap. Part the hair on the midline of the neck, between the base of the skull and the shoulder blades until the skin is visible. Place the tip of the applicator on the skin and apply the entire contents directly onto the skin in one spot. The product should be applied to dry skin on an area where the cat cannot lick it off. If the weight of the cat requires a second application, apply the contents in the same manner as described above in the same location. Wash hands after use with soap and water.
Do not administer orally. Cats may salivate excessively if NexGard® COMBO topical solution is accidentally administered orally or is ingested through licking/grooming the application site (see Target Animal Safety). Esafoxolaner, one of the ingredients in NexGard® COMBO, is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in cats receiving isoxazoline class drugs, even in cats without a history of seizures. Use with caution in cats with a history of seizures or neurologic disorders. The safety of NexGard® COMBO has not been tested in breeding, pregnant, or lactating cats. The safety of NexGard® COMBO has not been tested in kittens less than 8 weeks of age or weighing less than 1.8 lbs. The most frequently reported adverse reactions include vomiting, application site reactions, and anorexia.
The Boehringer Ingelheim Animal Health feline parasiticide portfolio includes several powerful products that keep your feline patients protected.
NexGard® is a registered trademark and NexGard COMBO™ is a trademark of Boehringer Ingelheim Animal Health France, used under license. BI-CONNECT™ and logo are trademarks of Boehringer Ingelheim Animal Health USA Inc. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.
NexGard® COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) is for topical use only in cats. Use with caution in cats with a history of seizures or neurologic disorders. The most frequently reported adverse reactions include vomiting, application site reactions, and anorexia. If ingested, hypersalivation may occur. Avoid direct contact with application site until visibly dry. For more information, click here for full prescribing information.